Antimicrobial resistance (AMR) is growing worldwide, yet many laboratories still rely on paper files or costly software that doesn’t fit their needs. When data is difficult to manage, it becomes harder to spot resistant infections early, share findings across countries, or protect patients in time.
To change this, the Surveillance and Epidemiology of Drug-Resistant Infections Committee (SEDRIC), with support from The Wellcome Trust, is developing SEDRI–LIMS, a free and open-source digital system created specifically for microbiology laboratories. Instead of being designed for highly resourced settings, this tool reflects the real needs of low- and middle-income countries. It helps laboratories securely manage test results, reduce errors, and connect easily with global AMR surveillance systems such as GLASS and ReLAVRA+.
SEDRI–LIMS is being shaped directly by the laboratories that will use it. The first pilot took place at CEMAR (Centro de Especialidades Médicas Ambulatorias) in Rosario, Argentina, where teams helped refine features to ensure the system works in real-world settings. The next implementation will begin in Suriname through the Fleming Fund.
By placing accessible, purpose-built technology in the hands of laboratory teams, SEDRI–LIMS supports better diagnosis, faster reporting, and a clearer picture of emerging resistance. With better data, countries can act sooner, strengthen public health decisions, and protect the effectiveness of life-saving antimicrobials.
SEDRI–LIMS helps laboratories do what they do best - safeguard the health of their communities.